Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Other Operating Expenses (2024 - 2026)

Carlsmed filings provide 2 years of Other Operating Expenses readings, the most recent being $13.2 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 2969.3% to $13.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.1 million, a N/A change, with the full-year FY2025 number at $43.3 million, up 101.77% from a year prior.
  • Other Operating Expenses hit $13.2 million in Q4 2025 for Carlsmed, up from $9.6 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $13.2 million in Q4 2025 to a low of $430000.0 in Q4 2024.